JetPeel is not abrasion in the way HydraFacial is. It fires a fast jet of saline and gas at your skin; nothing scrapes it. HydraFacial holds a spiral or diamond-grit tip against the skin and pulls the skin toward it with vacuum. JetPeel holds a nozzle a short distance away and lets the stream do the work. That is a genuinely different physical mechanism, not a different brand of the same thing.
In the only published description of the technology, the jet is a two-phase stream of gas and microdroplets of saline accelerated to supersonic velocities. That comes from a 2005 paper in Annals of Plastic Surgery, which called the effect gentle and accurate cosmetic peeling. There are no crystals, no grit, no spiral channel and no suction. The pressure of the stream against the skin is the entire mechanism.
No trial has ever compared JetPeel with HydraFacial, and JetPeel has exactly one clinical publication, from 2005. That paper followed 50 patients with no control group and no comparison treatment, and its authors wrote that further investigation was needed. Twenty years later, none has been published. HydraFacial has three small papers of its own, none of them a controlled trial against a sham or against a standard facial.
Neither device is FDA-cleared, because the category is exempt from FDA review. JetPeel's maker, TavTech Ltd of Israel, registers JetPeel, JetPro, JetPro Duo and JetPro TOGO with the FDA under product code GFE, "powered dermabrasion brush," 21 CFR 878.4820, Class I, 510(k) exempt. HydraFacial is registered in exactly the same category. There is no clearance number for either and no FDA-reviewed use for either. That is not the same as being unregulated. Registration, product listing, manufacturing quality rules and the prohibition on false labeling all still apply. It means no FDA reviewer has assessed what either machine does.
Made by TavTech Ltd of Yehud, Israel, and sold as JetPeel and JetPro. The company also has an older FDA listing, from 1999, for a jet lavage device called Jetox, which sits in the wound-irrigation category. The technology grew out of that lineage.
Made by Edge Systems, now HydraFacial LLC. The handpiece takes a disposable tip and works while touching the skin.
Compressed gas and saline are combined and pushed through a fine nozzle at very high speed. The stream strikes the skin, lifting away loose surface cells and pore contents. The operator controls the effect through nozzle distance, angle, pressure and how long the stream stays in one place.
The tip physically abrades the surface inside a film of fluid, while vacuum both holds the skin against the tip and draws the fluid and debris away into a waste jar. The company calls the swirling flow Vortex-Fusion.
No study has measured how much surface layer a JetPeel removes, or how far the saline travels into skin. The 2005 paper describes the clinical effect as a peel but reports no depth measurement.
An independent imaging study of 8 volunteers with Fitzpatrick skin types II to V measured the outer layer, the stratum corneum, at 9.42 micrometers before treatment and 6.67 micrometers straight after. Two weeks later it was 9.75 micrometers, slightly thicker than at the start.
No 510(k) exists for JetPeel, JetPro or TavTech. Class I, product code GFE, exempt. So there is no cleared use for wrinkles, acne, pores or anything else, because none was submitted or reviewed.
Same exempt classification. Edge Systems holds three FDA clearances in total, covering sterile tubing and the blue and red LED light modules, and none of them covers the abrasion and vacuum engine.
Fifty patients, treated and followed with no control group and no comparison. The authors reported the technology to be safe and effective for the usual reasons people have facial peeling, and found it most useful and effective around the mouth. They named the manufacturer's product and stated that further investigation was needed. Nothing else on JetPeel has been published since.
A randomized 2008 study of 20 women found changes on biopsy after six treatments with a serum, where the same serum applied by hand produced none. A 2022 open-label acne study of 20 adults, with a company employee among the authors, reported the share rated clear or almost clear rising from 20 to 65 percent. A 2024 imaging study of 8 volunteers found no visible collagen change at two weeks.
There is no tip dragging across the skin, so people who find abrasion or strong suction uncomfortable often prefer it. Published safety information is limited to the 2005 series, which reported the technology to be safe without a formal adverse event scale.
The usual account is pinkness for a few hours. The manufacturer of a closely related device lists a scratchy, stinging feeling during treatment and temporary tightness and redness afterwards, with severe irritation and allergic reactions listed as uncommon.
No professional society, no government source and no manufacturer publishes a price for JetPeel. Only clinic menus exist, and they are commercially interested. There is also no published guidance on how many sessions to have or how far apart, because no study has tested it.
RealSelf reported an average of $209 from 261 consumer-submitted reviews, with prices up to $320, last updated 13 July 2023. Self-reported, US-only and now several years old. Boosters and upgraded tiers cost more.
What the device does physically is well described. What is claimed for it is a much longer list.
The physical part is straightforward and comes from the manufacturer's own published account: gas and saline are combined and accelerated through a nozzle, and the resulting stream strikes the skin and lifts loose material off it. That is a mechanical effect, and it is not in dispute.
The longer list is where care is needed. Around this mechanism sit claims about delivering active ingredients into the skin, about tightening, about lifting and about rejuvenation. None of those has been measured for this device. The 2005 paper reports on appearance after treatment in 50 people, with no control group, no blinding and no comparison arm, which means it cannot separate the effect of the treatment from the effect of being treated, cleansed and photographed. Its authors said so themselves when they wrote that further investigation was needed.
A particular caution about the word "needle-free." It accurately describes how fluid leaves the machine: by pressure through a nozzle rather than through a needle. It does not establish that anything reaches the depth a needle would reach. Those are two different statements, and only the first one is supported.
The mechanism difference is the reason people describe these treatments so differently.
A HydraFacial involves a handpiece in contact with the skin, and a suction sensation that some people find odd and others find satisfying. The aggressiveness is set by which tip is fitted and how it is used; the manufacturer sells tips in named grades, including ones it labels Orange Aggression and Purple Aggression, which is a plain acknowledgement that the same machine can be run gently or firmly.
A JetPeel involves a nozzle held away from the skin and a cool, wet stream. There is nothing physically pressing on you. The operator still controls intensity, through distance, pressure and how long the stream dwells in one spot, so it is not automatically the gentler treatment. It is a different kind of input.
What neither difference tells you is which produces the better result, because that has never been tested.
Both devices are Class I, product code GFE, described in the regulation as a powered dermabrasion brush, and both are 510(k) exempt. Nobody has a clearance number for either. Nobody has an FDA-reviewed indication for either.
The exemption is a category rule, not a judgment about a particular machine. General controls still apply: the manufacturer must register with FDA, list the product, follow manufacturing quality requirements, and must not label the product falsely or misleadingly. What does not apply is any premarket assessment of whether it works.
If a clinic tells you a device facial is FDA-cleared, it is a claim that has come from a clinic or a distributor. It is worth knowing that distributors in this market do make that claim in writing, and that in at least one documented case the claim was made about a device that is exempt and has no clearance at all.
Tell your provider if you get cold sores. Antiviral medicine has to be started before the appointment, not after it, because it needs to be working before the skin is treated.
Say if your skin is currently sore, sunburned, broken or inflamed, and mention retinoids or strong acids you are using at home. A related manufacturer's own instruction is not to treat skin whose quality is already compromised.
Ask about eye protection. Both treatments involve fluid moving fast near your eyes. The one clearly documented injury in the public record for this device family is acidic fluid reaching a patient's eyes because they were not shielded.
If your skin is deeper in tone, say so and ask the operator to keep the suction and the abrasion gentle. Any irritation in richly pigmented skin can leave post-inflammatory hyperpigmentation — dark patches that stay behind after the skin is inflamed. There is no published safety data for this treatment specific to darker skin tones, and the single consumer report of lasting color change in FDA's database came from a patient with dark skin, so this is caution rather than a measured risk.